Turtschi, Christian P. External Entity

Publications

Sort by

Selected publications

  • A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors.  Clinical cancer research : an official journal of the American Association for Cancer Research2014 Academic Article GET IT
    Times cited: 79

Other